Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
san diego blog main
san francisco blog main
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
bluebird bio
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
cancer vaccine
chronic kidney disease
detroit blog main
detroit top stories
duchenne muscular dystrophy
dyne therapeutics
facioscapulohumeral muscular dystrophy
fda
food and drug administration
forty seven
gene therapy
indiana blog main
indiana top stories
investing
ipo
joshua brumm
kaleido biosciences
major depressive disorder
medical device
What
biotechs
2
×
ipo
therapeutics
2
×
ago
club
companies
considering
continued
crop
data
diseases
drug
dyne
early
exceeded
expected
experimental
eyes
firms
genetic
group
haul
having
humans
ipos
joined
latest
life
long
medicines
met
million
momentum
muscle
nasdaq
neon
new
offerings
positive
projections
Language
unset
Current search:
biotechs
×
therapeutics
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
